Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (101)	5/11/1998 8:43:00 AM
From: Jim Oravetz	Read Replies (2) of 370

TDude: I would not blame IR just yet. Even thought they are still a small operation (> 100 person), they may not directly send out Inv. Info pkges. They may just forward the request to a mailing house and count on them for the follow through. I requested an annual report through the WSJ "Annual Report" service. It took 3-4 weeks to get to me, but I did receive it. As far as up to date info on thier products and research, they have a pretty current web page (www.vionpham.com (?)) with resent articles and press releases. You could also find SEC reports (10K's etc) on the EDGAR system since all companies are required to submit electronic form reports. BTW, the stockholders Annual meeting will be held next Tuesday, May 19th in New Haven, CT I am bullish on this company but do not presently own any stock. Thier research looks very interesting and promising. They seem to be getting some nice funding as well. Good luck on your info hunting. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next